血管生成是由已有血管生成新的血管的生理过程。血管生成发生在不同的生理过程中，例如胚胎发育、月经周期、运动和伤口愈合等。血管生成受到内源性激活剂及抑制剂的调控，一些主要的内源性激动剂包括 VEGF、bFGF、angiogenin、TGF-β 等，一些主要的内源性抑制剂包括 angiostatin、endostatin、interferon、platelet factor 4 等。血管生成调控失调会引起多种疾病的发生，如癌症、心血管疾病及缺血性疾病等。激活血管生成可以对心血管疾病及缺血性疾病起到一定控制作用，而抑制血管生成可以对癌症发挥一定治疗作用。
Chem960 可以提供 靶向血管生成相关靶点及信号通路的小分子化合物，Chem960 血管生成化合物库是进行血管生成相关研究及开发靶向血管生成药物的有效工具。
• A unique collection of 101 small molecule compounds with validated angiogenesis targets modulating properties.
• Targeting diverse targets, including VEGFR, Ephrin Receptor, PDGFR, FGFR, etc.
• A useful tool for the research of transcription factor-related regulation and diseases.
• Bioactivity and safety confirmed by preclinical research and clinical trials. Some have been approved by FDA.
• Structurally diverse, medicinally active, and cell permeable.
• Detailed compound information with structure, IC50, and brief introduction.
• Validated NMR and HPLC to ensure high purity and quality.
• All compounds are in stock and continuously updated.
